LAWSUITS NEWS & LEGAL INFORMATION
Diabetes Drugs Legal News Articles & Interviews
- Attorneys and Victims Undeterred by Recent Actos Verdict By Jane Mundy (May-16-13)
- Attorney Advises Januvia Pancreatitis Victim By Jane Mundy (May-13-13)
- Actos Lawsuit Verdict Encouraging for Actos Victims By Jane Mundy (May-1-13)
- Januvia Pancreatic Cancer Risk Being Studied by the FDA By Gordon Gibb (Apr-28-13)
- Januvia Attorney: Januvia Lawsuits Moving Ahead By Heidi Turner (Apr-20-13)
- Diabetes Meds Avandia and Januvia Under Renewed Scrutiny by FDA By Lucy Campbell (Apr-17-13)
- Diabetes Drug Lawsuit Update: Actos, Byetta, Januvia By Heidi Turner (Apr-12-13)
- Januvia and Byetta Increase Pancreatic and Neuroendocrine Cancer Risk By Lucy Campbell (Apr-1-13)
- FDA Opens Investigation into Januvia and Pancreatitis By Lucy Campbell (Mar-25-13)
- FDA Launches New Evalution into Link Between Type 2 Diabetes Meds and Pancreatitis By Lucy Campbell (Mar-14-13)
- Januvia Studies Link Medication to Serious Side Effects By Heidi Turner (Mar-8-13)
- Pancreatitis Risk Doubles with Januvia and Byetta JAMA Study Shows By Lucy Campbell (Feb-26-13)
- Actos Lawsuit Plaintiff: If Only He Had Known the Risks By Gordon Gibb (Feb-20-13)
- Will Continued Growth for Januvia Translate to Increased Januvia Side Effects? By Gordon Gibb (Feb-19-13)
- More Actos Lawsuits Filed By Heidi Turner (Feb-5-13)
- New Diabetes Drug May Compete with Januvia By Heidi Turner (Feb-2-13)
- FDA Warnings For Actos Bladder Cancer Came Too Late For Some By Gordon Gibb (Jan-11-13)
- Actos Bladder Cancer: The Meaning Behind 'Maybe' By Gordon Gibb (Dec-23-12)
- Studies Suggest Link Between Actos and Bladder Cancer By Heidi Turner (Dec-8-12)
- Actos Among Group of Four With Higher Reports of Side Effects By Gordon Gibb (Nov-24-12)
- Still More Actos Bladder Cancer Lawsuits Are Filed By Heidi Turner (Nov-10-12)
- Januvia Patients Face Increased Risk of Pancreatitis By Heidi Turner (Nov-3-12)
- The Weight Behind Consumers Reports Warning Against Actos By Gordon Gibb (Oct-29-12)
- Actos Bladder Cancer Lawsuits Still Being Filed By Heidi Turner (Oct-8-12)
- Consumer Reports Warns About Actos Side Effects By Heidi Turner (Sep-29-12)
- Just Two of a Potential 10,000 Actos Bladder Cancer Lawsuits By Gordon Gibb (Sep-7-12)
- Another Study Finds Link Between Actos and Bladder Cancer By Heidi Turner (Aug-25-12)
- New Owners Gambling Bydureon Won’t Be Another Byetta By Gordon Gibb (Aug-12-12)
- Class Action Lawsuit in Canada Alleges Actos Bladder Cancer By Gordon Gibb (Aug-11-12)
- New Study Suggests Actos Bladder Cancer Link By Heidi Turner (Jul-24-12)
- FDA Accuses Amylin of Withholding Byetta Safety Information By Heidi Turner (Jul-7-12)
- Yet Another Actos Bladder Cancer Lawsuit By Gordon Gibb (Jul-5-12)
- Study: Actos Linked to Macular Edema By Heidi Turner (Jun-22-12)
- Actos Bladder Cancer Risk Doubles Two Years Out By Gordon Gibb (Jun-8-12)
- What Can Patients Believe About Byetta? By Heidi Turner (Jun-1-12)
- FDA Petitioned to Remove Diabetes Med Victoza (Liraglutide) from the Market By Lucy Campbell (May-30-12)
- Another Actos Lawsuit Filed By Heidi Turner (May-26-12)
- Is There a New Indication for Actos in the Works? By Gordon Gibb (May-18-12)
- Health Canada Issues Actos Warning By Heidi Turner (May-9-12)
- Byetta Manufacturer Reportedly at a Crossroads By Gordon Gibb (May-2-12)
- Health Canada: Actos and Bladder Cancer Are Linked By Charles Benson (Apr-26-12)
- Actos Bladder Cancer Whistleblower Lawsuit Unsealed By Gordon Gibb (Apr-15-12)
- How Safe Is Actos? By Heidi Turner (Apr-8-12)
- Byetta Side Effects Do Not Stop Additional Use Approval By Heidi Turner (Apr-6-12)
- Actos Lawsuit Moves Forward By Heidi Turner (Mar-28-12)
- Actos Whistleblower Claims Takeda Downplayed CHF Data By Lucy Campbell (Mar-19-12)
- Actos Bladder Cancer MDL Litigation Lurches Forward to March 22 Start By Gordon Gibb (Mar-18-12)
- Actos Lawsuit Alleges Side Effects Hidden By Heidi Turner (Mar-9-12)
- Byetta Patients Must Be Aware of the Risks By Heidi Turner (Mar-4-12)
- Concern Over Actos Bladder Cancer Mounts, Takeda to Cut Workforce By Gordon Gibb (Feb-26-12)